Jun 15, 2022 / 10:20PM GMT
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst
All right. Good afternoon, everyone. I'm Matt Sykes, the Life Science Tools and Diagnostics analyst at Goldman Sachs, and I have the pleasure of welcoming Cue Health to our conference this afternoon. We have John Gallagher, the Chief Financial Officer of Cue Health, John. Thanks for coming.
John E. Gallagher - Cue Health Inc. - CFO
Thank you, Matt. Appreciate being here.
Questions and Answers:
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research AnalystNo problem. Maybe I'll let you kind of set the stage first and talk about some of the key accomplishments over the past 6 to 12 months. It's been a busy time for you. And maybe just reflect on some of the most recent results and some of the goals that you have for this year as you look out into '23?
John E. Gallagher - Cue Health Inc. - CFO
Yes, Matt, it's -- as I look back over the last 6 to 12 months,
Trustpilot
